Biosimilar Post-Approval Change Guidance Coming From US FDA

 
• By Derrick Gingery
  
Binoculars hang on a wooden fence background
Biosimilar sponsors' postmarket responsibilities may be coming into more focus.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance